Caris Life Sciences (CAI) Other financing activities (2024 - 2026)

Caris Life Sciences' Other financing activities history runs 3 years deep, the most recent figure standing at $920000.0 for Q1 2026.

• On a quarterly basis, Other financing activities fell 35.84% year-over-year to $920000.0 in Q1 2026; TTM through Mar 2026 was $527.9 million, a N/A change from a year earlier, with the FY2025 full-year figure at $528.5 million, changed N/A from the prior year.
• Other financing activities declined to $920000.0 in Q1 2026 per CAI's latest filing, from $518.2 million in the prior quarter.
• Across five years, Other financing activities topped out at $518.2 million in Q4 2025 and bottomed at -$1.3 million in Q4 2024.
• The 3-year median for Other financing activities is $1.2 million (2025), against an average of $75.5 million.
• Across the five-year window, Other financing activities jumped 41291.49% in 2025 and plunged 35.84% in 2026, its largest moves.
• Year by year, Other financing activities stood at -$1.3 million in 2024, then soared by 41291.49% to $518.2 million in 2025, then slumped by 99.82% to $920000.0 in 2026.
• Per Business Quant, the three latest CAI Other financing activities figures stand at $920000.0 (Q1 2026), $518.2 million (Q4 2025), and $7.6 million (Q3 2025).